ArticleDiabetes, obesity & metabolism2026

Time-Dependent Accrual of Cardiorenal Benefit With SGLT2 Inhibitors in Chronic Kidney Disease: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials.

Shotaro Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.